Bruker showcases high-performance solutions at Analytica 2024 for research and analysis in applied, industrial and biopharma laboratories

FHS
April 9, 2024
11:34 am

Bruker Corporation (Nasdaq: BRKR) is showcasing some of its latest innovations at Analytica 2024:

Intellia cuts 27% of staff, in the latest wave of gene-editing layoffs

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Ready for

January 10, 2025

Therapeutic Potential of Psychedelics for Older Adults | Psychedelic Invest

Psychedelics such as DMT, LSD, and psilocybin have shown significant potential in treating affective symptoms across a variety of disorders. These substances induce altered states

July 22, 2024

Perioperative immunotherapy improves event-free survival in patients with resectable NSCLC

Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable

May 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.